|
1
|
Stenmark KR and McMurtry IF: Vascular
remodeling versus vasoconstriction in chronic hypoxic pulmonary
hypertension: A time for reappraisal? Circ Res. 97:95–98. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stenmark KR, Fagan KA and Frid MG:
Hypoxia-induced pulmonary vascular remodeling: Cellular and
molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lendahl U, Zimmerman LB and McKay RD: CNS
stem cells express a new class of intermediate filament protein.
Cell. 60:585–595. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kachinsky AM, Dominov JA and Miller JB:
Intermediate filaments in cardiac myogenesis: Nestin in the
developing mouse heart. J Histochem Cytochem. 43:843–847. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oikawa H, Hayashi K, Maesawa C, Masuda T
and Sobue K: Expression profiles of nestin in vascular smooth
muscle cells in vivo and in vitro. Exp Cell Res. 316:940–950. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Helou V, Chabot A, Gosselin H,
Villeneuve L, Clavet-Lanthier ME, Tanguay JF, Enikolopov G,
Fernandes KJ, Jasmin JF and Calderone A: Cardiac resident nestin(+)
cells participate in reparative vascularisation. J Cell Physiol.
228:1844–1853. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishiwata T, Matsuda Y and Naito Z: Nestin
in gastrointestinal and other cancers: Effects on cells and tumor
angiogenesis. World J Gastroenterol. 17:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Béguin PC, Gosselin H, Mamarbachi M and
Calderone A: Nestin expression is lost in ventricular fibroblasts
during postnatal development of the rat heart and re-expressed in
scar myofibroblasts. J Cell Physiol. 227:813–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sejersen T and Lendahl U: Transient
expression of the intermediate filament nestin during skeletal
muscle development. J Cell Sci. 106:1291–1300. 1993.PubMed/NCBI
|
|
10
|
Vaittinen S, Lukka R, Sahlgren C, Hurme T,
Rantanen J, Lendahl U, Eriksson JE and Kalimo H: The expression of
intermediate filament protein nestin as related to vimentin and
desmin in regenerating skeletal muscle. J Neuropath Exp Neur.
60:588–597. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frisén J, Johansson CB, Török C, Risling M
and Lendahl U: Rapid, widespread, and longlasting induction of
nestin contributes to the generation of glial scar tissue after CNS
injury. J Cell Biol. 131:453–464. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Daniel C, Albrecht H, Lüdke A and Hugo C:
Nestin expression in repopulating mesangial cells promotes their
proliferation. Lab Invest. 88:387–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hisa T, Kimura Y, Takada K, Suzuki F and
Takigawa M: Shikonin, an ingredient of Lithospermum erythrorhizon,
inhibits angiogenesis in vivo and in vitro. Anticancer Res.
18:783–790. 1998.PubMed/NCBI
|
|
14
|
Chen X, Yang L, Oppenheim JJ and Howard
MZ: Cellular pharmacology studies of shikonin derivatives.
Phytother Res. 16:199–209. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papageorgiou VP, Assimopoulou AN and
Ballis AC: Alkannins and shikonins: A new class of wound healing
agents. Curr Med Chem. 15:3248–3267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tanaka S, Tajima M, Tsukada M and Tabata
M: A comparative study on anti-inflammatory activities of the
enantiomers, shikonin and alkannin. J Nat Prod. 49:466–469. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sankawa U, Ebizuka Y, Miyazaki T, Isomura
Y and Otsuka H: Antitumor activity of shikonin and its derivatives.
Chem Pharm Bull (Tokyo). 25:2392–2395. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jang SY, Hong D, Jeong SY and Kim JH:
Shikonin causes apoptosis by up-regulating p73 and down-regulating
ICBP90 in human cancer cells. Biochem Biophys Res Commun.
465:71–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang ZQ, Cao XC, Zhang L and Zhu WL:
Effect of shikonin, a phytocompound from Lithospermum
erythrorhizon, on rat vascular smooth muscle cells proliferation
and apoptosis in vitro. Zhonghua Yi Xue Za Zhi. 85:1484–1488.
2005.(In Chinese). PubMed/NCBI
|
|
20
|
Liu J, Da ZK, Li Z, Xue YX, Liu LB, Wang P
and Liu YH: Effects of shikonin on sternness maintance of glioma
stem cells. Chin Pharmacol Bull. 1:49–54. 2016.
|
|
21
|
García-Blanco A, Bulnes S, Pomposo I,
Carrasco A and Lafuente JV: Nestin+cells forming spheroids
aggregates resembling tumorspheres in experimental ENU-induced
gliomas. Histol Histopathol. 31:1347–1356. 2016.PubMed/NCBI
|
|
22
|
National Institutes of Health (NIH), .
Guide for the Care and Use of Laboratory Animals. The National
Academies Press; Washington D.C.: 1996
|
|
23
|
He ZM, Li GP, Zhu DS and Lu SM: Guidelines
for the management and use of experimental animals. State Science
and Technology Academic Publication Fund Committee and Science and
Technology Press; Beijing: pp. 80–115. 2016
|
|
24
|
Gunther S, Alexander RW, Atkinson WJ and
Gimbrone MA Jr: Functional angiotensin II receptors in cultured
vascular smooth muscle cells. J Cell Biol. 92:289–298. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagamoto T, Eguchi G and Beebe DC:
Alpha-smooth muscle actin expression in cultured lens epithelial
cells. Invest Ophthalmol Vis Sci. 41:1122–1129. 2000.PubMed/NCBI
|
|
26
|
Hawryłkiewicz I: Hypoxic pulmonary
hypertension-chronic cor pulmonale. Pneumonol Alergol Pol.
71:562–568. 2003.PubMed/NCBI
|
|
27
|
Archer SL, Huang JM, Reeve HL, Hampl V,
Tolarová S, Michelakis E and Weir EK: Differential distribution of
electrophysiologically distinct myocytes in conduit and resistance
arteries determines their response to nitric oxide and hypoxia.
Circ Res. 78:431–442. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sabatini F, Petecchia L, Tavian M, de
Villeroché Jodon V, Rossi GA and Brouty-Boyé D: Human bronchial
fibroblasts exhibit a mesenchymal stem cell phenotype and
multilineage differentiating potentialities. Lab Invest.
85:962–971. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suguta M, Nakano A, Hoshino Y, Endoh M,
Hatori T, Hasegawa A, Aihara M, Takeuchi T and Kurabayashi M:
Nestin, a maker for multilineage potential of cells from human
primary and restenotic coronary artery plaques. Int J Cardiol.
121:53–56. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang YL, Shi GY, Jiang MJ, Lee H, Chou
YW, Wu HL and Yang HY: Epidermal growth factor up-regulates the
expression of nestin through the Ras-Raf-ERK signaling axis in rat
vascular smooth muscle cells. Biochem Biophys Res Commun.
377:361–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang YL, Shi GY, Lee H, Jiang MJ, Huang
BM, Wu HL and Yang HY: Thrombin induces nestin expression via the
transactivation of EGFR signalings in rat vascular smooth muscle
cells. Cell Signal. 21:954–968. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saboor F, Reckmann AN, Tomczyk CU, Peters
DM, Weissmann N, Kaschtanow A, Schermuly RT, Michurina TV,
Enikolopov G, Müller D, et al: Nestin-expressing vascular wall
cells drive development of pulmonary hypertension. Eur Respir J.
47:876–888. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sakairi T, Hiromura K, Yamashita S,
Takeuchi S, Tomioka M, Ideura H, Maeshima A, Kaneko Y, Kuroiwa T,
Nangaku M, et al: Nestin expression in the kidney with an
obstructed ureter. Kidney Int. 72:307–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sahlgren CM, Pallari HM, He T, Chou YH,
Goldman RD and Eriksson JE: A nestin scaffold links Cdk5/p35
signaling to oxidant-induced cell death. Embo J. 25:4808–4819.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang YL, Wu CM, Shi GY, Wu GC, Lee H,
Jiang MJ, Wu HL and Yang HY: Nestin serves as a prosurvival
determinant that is linked to the cytoprotective effect of
epidermal growth factor in rat vascular smooth muscle cells. J
Biochem. 146:307–315. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Singh F, Gao D, Lebwohl MG and Wei H:
Shikonin modulates cell proliferation by inhibiting epidermal
growth factor receptor signaling in human epidermoid carcinoma
cells. Cancer Lett. 200:115–121. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen CH, Chern CL, Lin CC, Lu FJ, Shih MK,
Hsieh PY and Liu TZ: Involvement of reactive oxygen species, but
not mitochondrial permeability transition in the apoptotic
induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med.
69:1119–1124. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Min R, Tong J, Wenjun Y, Wenhu D, Xiaojian
Z, Jiacai H, Jian Z, Wantao C and Chenping Z: Growth inhibition and
induction of apoptosis in human oral squamous cell carcinoma
Tca-8113 cell lines by Shikonin was partly through the inactivation
of NF-kappaB pathway. Phytother Res. 22:407–415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian R, Li Y and Gao M: Shikonin causes
cell-cycle arrest and induces apoptosis by regulating the
EGFR-NF-κB signalling pathway in human epidermoid carcinoma A431
cells. Biosci Rep. 35:pii: e00189. 2015. View Article : Google Scholar
|
|
40
|
Zhang X, Hu W, Yuan X and Hu J: Shikonin
inhibits TNF-α-induced growth and invasion of rat aortic vascular
smooth muscle cells. Can J Physiol Pharmacol. 93:615–624. 2015.
View Article : Google Scholar : PubMed/NCBI
|
